BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

526 related articles for article (PubMed ID: 31684983)

  • 1. Evaluating the optimal re-irradiation dose for locally recurrent esophageal squamous cell carcinoma after definitive radiotherapy.
    Xu X; Wang Z; Jiang S; Shang Y; Wu Y
    Radiat Oncol; 2019 Nov; 14(1):191. PubMed ID: 31684983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A re-irradiation dose of 55-60 Gy improves the survival rate of patients with local recurrent esophageal squamous cell carcinoma after radiotherapy.
    Wu X; Hu X; Chen J; He L
    Radiat Oncol; 2021 Jun; 16(1):100. PubMed ID: 34103059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-irradiation for local primary-recurrence esophageal squamous cell carcinoma treated with IMRT/VMAT.
    Xiang G; Xu C; Chai G; Lyu B; Li Z; Wang B; Shi M; Zhao L
    Radiat Oncol; 2023 Jul; 18(1):114. PubMed ID: 37430276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival benefit of re-irradiation in esophageal Cancer patients with Locoregional recurrence: a propensity score-matched analysis.
    Hong L; Huang YX; Zhuang QY; Zhang XQ; Tang LR; Du KX; Lin XY; Zheng BH; Cai SL; Wu JX; Li JL
    Radiat Oncol; 2018 Sep; 13(1):171. PubMed ID: 30201005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and toxicity of re-irradiation for esophageal cancer patients with locoregional recurrence: a retrospective analysis.
    Zhao K; Si Y; Sun L; Meng X; Yu J
    Radiat Oncol; 2020 Oct; 15(1):243. PubMed ID: 33087143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer.
    Rühle A; Sprave T; Kalckreuth T; Stoian R; Haehl E; Zamboglou C; Laszig R; Knopf A; Grosu AL; Nicolay NH
    Radiat Oncol; 2020 Apr; 15(1):81. PubMed ID: 32299456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic analysis of definitive radiotherapy for early esophageal carcinoma(T1-2N0M0): a multi-center retrospective study of Jing-Jin-ji Esophageal and Esophagogastric Cancer Radiotherapy Oncology Group].
    Lu N; Wang X; Li C; Wang L; Chen JQ; Zhang WC; Wang XM; Ge XL; Shen WB; Hu MM; Yuan QQ; Xu YG; Hao CL; Zhou ZG; Qie S; Xiao ZF; Zhu SC; Han C; Qiao XY; Pang QS; Wang P; Zhao YD; Sun XC; Zhang KX; Li L; Li GF; Liu ML; Wang YD
    Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):139-144. PubMed ID: 32135649
    [No Abstract]   [Full Text] [Related]  

  • 8. The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma.
    Ning ZH; Zhao W; Li XD; Chen LJ; Xu B; Gu WD; Shao YJ; Xu Y; Huang J; Pei HL; Jiang JT
    Int J Clin Exp Pathol; 2015; 8(6):6881-90. PubMed ID: 26261575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose salvage re-irradiation for recurrent/progressive adult diffuse glioma: healing or hurting?
    Gupta T; Maitre M; Maitre P; Goda JS; Krishnatry R; Chatterjee A; Moiyadi A; Shetty P; Epari S; Sahay A; Patil V; Jalali R
    Clin Transl Oncol; 2021 Jul; 23(7):1358-1367. PubMed ID: 33528810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-irradiation for oligo-recurrence from esophageal cancer with radiotherapy history: a multi-institutional study.
    Jingu K; Niibe Y; Yamashita H; Katsui K; Matsumoto T; Nishina T; Terahara A
    Radiat Oncol; 2017 Sep; 12(1):146. PubMed ID: 28870211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of pulsed low-dose rate radiotherapy for local recurrent esophageal squamous cell carcinoma after radiotherapy: Study protocol for a prospective multi-center phase II trial.
    Li J; Zhao Z; Du G; Dai T; Zhen X; Cai H; Liao D; Xiang M; Wen Y; Geng L; Yang X; Feng G; Zhang Y; Bai J; Liu L; Du X
    Medicine (Baltimore); 2019 Jun; 98(26):e16176. PubMed ID: 31261551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Prospective Study of Proton Beam Reirradiation for Esophageal Cancer.
    Fernandes A; Berman AT; Mick R; Both S; Lelionis K; Lukens JN; Ben-Josef E; Metz JM; Plastaras JP
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):483-487. PubMed ID: 26847847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Outcomes and Prognostic Factors of Patients With Esophageal Squamous Cell Carcinoma With Oligo-recurrence Treated With Radical Re-irradiation.
    Lin CY; Fang HY; Lein MY; Lin CC; Bai LY; Tsai MH; Chen CC; Hsieh TC; Wang YC; Liang JA; Li CC; Chien CR
    Anticancer Res; 2020 Apr; 40(4):2387-2392. PubMed ID: 32234942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-irradiation for locoregionally recurrent tumors of the thorax: a single-institution, retrospective study.
    Sumita K; Harada H; Asakura H; Ogawa H; Onoe T; Murayama S; Nakamura S; Tanigawa N; Takahashi T; Nishimura T
    Radiat Oncol; 2016 Aug; 11():104. PubMed ID: 27485533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-escalated re-irradiation improves outcome in locally recurrent head and neck cancer - Results of a large multicenter analysis.
    Roesch J; Oertel M; Wegen S; Trommer M; Schleifenbaum J; Hering D; Mäurer M; Knippen S; Dobiasch S; Waltenberger M; von der Grün J; Medenwald D; Süß C; Hoeck M; Käsmann L; Fleischmann DF; Rühle A; Nicolay NH; Fabian A; Löser A; Heß S; Tamaskovics B; Vinsensia M; Hecht M;
    Radiother Oncol; 2023 Apr; 181():109380. PubMed ID: 36273736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the optimal radiation dose for definitive chemoradiotherapy for esophageal squamous cell carcinoma: A single institution experience.
    Ke TM; Fong Y; Lin LC; Chien YW; Yang CC; Lin CH; Lin KL; Que J
    Medicine (Baltimore); 2018 Nov; 97(46):e13214. PubMed ID: 30431596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involved-Field Irradiation in Definitive Chemoradiotherapy for Locoregional Esophageal Squamous Cell Carcinoma: Results From the ESO-Shanghai 1 Trial.
    Zhu H; Rivin Del Campo E; Ye J; Simone CB; Zhu Z; Zhao W; Amini A; Zhou J; Wu C; Tang H; Fan M; Li L; Lin Q; Xia Y; Li Y; Li J; Mo M; Jia H; Lu S; Wang J; Nie Y; Chen J; Wu S; Hamaji M; Haque W; Jeong BK; Shridhar R; Zhang Z; Chen Y; Zhao K
    Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1396-1406. PubMed ID: 33677048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors, patterns of recurrence and toxicity for patients with esophageal cancer undergoing definitive radiotherapy or chemo-radiotherapy.
    Haefner MF; Lang K; Krug D; Koerber SA; Uhlmann L; Kieser M; Debus J; Sterzing F
    J Radiat Res; 2015 Jul; 56(4):742-9. PubMed ID: 25907360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of the nodal status on the overall survival of non-surgical patients with esophageal squamous cell carcinoma.
    Zhao Z; Zhang Y; Wang P; Wang X; Li M
    Radiat Oncol; 2019 Sep; 14(1):161. PubMed ID: 31481064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-irradiation for locally recurrent refractory breast cancer.
    Merino T; Tran WT; Czarnota GJ
    Oncotarget; 2015 Oct; 6(33):35051-62. PubMed ID: 26459388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.